1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Option (right to buy)
(3)
|
02/16/2008 |
02/15/2017 |
Common shares
|
27,667
|
$
25.2461
|
D
|
Â
|
Option (right to buy)
(3)
|
02/16/2009 |
02/15/2017 |
Common shares
|
27,666
|
$
25.2461
|
D
|
Â
|
Option (right to buy)
(3)
|
02/16/2010 |
02/15/2017 |
Common shares
|
27,667
|
$
25.2461
|
D
|
Â
|
Option (right to buy)
(3)
|
02/15/2009 |
02/14/2018 |
Common shares
|
26,234
|
$
26.6973
|
D
|
Â
|
Option (right to buy)
(3)
|
02/15/2010 |
02/14/2018 |
Common shares
|
26,233
|
$
26.6973
|
D
|
Â
|
Option (right to buy)
(3)
|
02/15/2011 |
02/14/2018 |
Common shares
|
26,233
|
$
26.6973
|
D
|
Â
|
Option (right to buy)
(3)
|
02/20/2010 |
02/19/2019 |
Common shares
|
12,900
|
$
26.015
|
D
|
Â
|
Option (right to buy)
(3)
|
02/20/2011 |
02/19/2019 |
Common shares
|
12,900
|
$
26.015
|
D
|
Â
|
Option (right to buy)
(3)
|
02/20/2012 |
02/19/2019 |
Common shares
|
12,900
|
$
26.015
|
D
|
Â
|
Option (right to buy)
(4)
|
02/19/2011 |
02/18/2020 |
Common shares
|
9,567
|
$
26.1879
|
D
|
Â
|
Option (right to buy)
(4)
|
02/19/2012 |
02/18/2020 |
Common shares
|
9,566
|
$
26.1879
|
D
|
Â
|
Option (right to buy)
(4)
|
02/19/2013 |
02/18/2020 |
Common shares
|
9,567
|
$
26.1879
|
D
|
Â
|
Option (right to buy)
(4)
|
02/18/2012 |
02/17/2021 |
Common shares
|
16,700
|
$
22.3919
|
D
|
Â
|
Option (right to buy)
(4)
|
02/18/2013 |
02/17/2021 |
Common shares
|
16,700
|
$
22.3919
|
D
|
Â
|
Option (right to buy)
(4)
|
02/18/2014 |
02/17/2021 |
Common shares
|
16,700
|
$
22.3919
|
D
|
Â
|
Option (right to buy)
(4)
|
02/17/2013 |
02/16/2022 |
Common shares
|
18,334
|
$
27.0336
|
D
|
Â
|
Option (right to buy)
(4)
|
02/17/2014 |
02/16/2022 |
Common shares
|
18,333
|
$
27.0336
|
D
|
Â
|
Option (right to buy)
(4)
|
02/17/2015 |
02/16/2022 |
Common shares
|
18,333
|
$
27.0336
|
D
|
Â
|
Option (right to buy)
(4)
|
03/01/2013 |
08/02/2014 |
Common shares
|
6,247
|
$
31.4255
|
D
|
Â
|
Option (right to buy)
(4)
|
03/08/2013 |
02/19/2014 |
Common shares
|
21,972
|
$
32.1559
|
D
|
Â
|
Option (right to buy)
(4)
|
03/08/2013 |
08/02/2014 |
Common shares
|
11,956
|
$
32.1559
|
D
|
Â
|
Option (right to buy)
(4)
|
02/15/2014 |
02/14/2023 |
Common shares
|
55,000
|
$
34.94
|
D
|
Â
|
Option (right to buy)
(4)
|
02/15/2015 |
02/14/2023 |
Common shares
|
55,000
|
$
34.94
|
D
|
Â
|
Option (right to buy)
(4)
|
02/15/2016 |
02/14/2023 |
Common shares
|
55,000
|
$
34.94
|
D
|
Â
|
Option (right to buy)
(4)
|
02/17/2014 |
02/19/2014 |
Common shares
|
1,583
|
$
35.03
|
D
|
Â
|
* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
Balance in the Abbott Laboratories Stock Retirement Trust as of October 14, 2013. |
(2) |
The reporting person disclaims beneficial ownership of all securities held by his son. |
(3) |
Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
(4) |
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |